Pages that link to "Q46463342"

The following pages link to Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer (Q46463342):

Displaying 25 items.

• Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern Europe (Q33561895) (← links)
• Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck (Q33615319) (← links)
• Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck (Q33828852) (← links)
• A single nucleotide polymorphism in the alcohol dehydrogenase 7 gene (alanine to glycine substitution at amino acid 92) is associated with the risk of squamous cell carcinoma of the head and neck (Q33936527) (← links)
• Association between novel PLCE1variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck (Q33937401) (← links)
• Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study. (Q34121847) (← links)
• Prognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma (Q34126506) (← links)
• Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor (Q34178135) (← links)
• Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck (Q35613443) (← links)
• Vitamin D receptor as a master regulator of the c-MYC/MXD1 network (Q36414642) (← links)
• Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women (Q36465327) (← links)
• Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population (Q36638586) (← links)
• Vitamin D signalling pathways in cancer: potential for anticancer therapeutics (Q36919979) (← links)
• Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. (Q36947851) (← links)
• Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study (Q37105113) (← links)
• Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. (Q37214192) (← links)
• Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. (Q37233335) (← links)
• p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck (Q37376471) (← links)
• Improved renal allograft survival with vitamin D receptor polymorphism (Q46906611) (← links)
• Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis. (Q47217714) (← links)
• Association of the vitamin D receptor FokI gene polymorphism with sex- and non-sex-associated cancers: A meta-analysis (Q47608832) (← links)
• Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis. (Q53150021) (← links)
• Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck (Q80574208) (← links)
• Vitamin D intake and survival and recurrence in head and neck cancer patients (Q88657613) (← links)
• Association of select vitamin D receptor gene polymorphisms with the risk of tobacco-related cancers - a meta-analysis (Q91130168) (← links)